vs

Side-by-side financial comparison of FIRST MERCHANTS CORP (FRME) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $157.1M, roughly 1.3× FIRST MERCHANTS CORP). FIRST MERCHANTS CORP runs the higher net margin — 17.9% vs 6.7%, a 11.2% gap on every dollar of revenue. Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -0.9%).

First Merchants Corporation is a financial holding company in Central Indiana, headquartered in Muncie, Indiana. The Corporation includes First Merchants Bank and First Merchants Private Wealth Advisors. The company is listed on the NASDAQ as FRME. As of March 2023, total asset size of First Merchants Corporation was $18.2 billion. First Merchants offers commercial banking, personal banking, and investment advisor services.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FRME vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$157.1M
FRME
Higher net margin
FRME
FRME
11.2% more per $
FRME
17.9%
6.7%
RGEN
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-0.9%
FRME

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FRME
FRME
RGEN
RGEN
Revenue
$157.1M
$197.9M
Net Profit
$28.2M
$13.3M
Gross Margin
52.5%
Operating Margin
9.0%
Net Margin
17.9%
6.7%
Revenue YoY
13.6%
Net Profit YoY
-49.1%
143.9%
EPS (diluted)
$0.45
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FRME
FRME
RGEN
RGEN
Q1 26
$157.1M
Q4 25
$172.2M
$197.9M
Q3 25
$166.1M
$188.8M
Q2 25
$164.3M
$182.4M
Q1 25
$160.3M
$169.2M
Q4 24
$177.1M
$174.1M
Q3 24
$156.0M
$154.9M
Q2 24
$159.9M
$154.1M
Net Profit
FRME
FRME
RGEN
RGEN
Q1 26
$28.2M
Q4 25
$57.1M
$13.3M
Q3 25
$56.8M
$14.9M
Q2 25
$56.8M
$14.9M
Q1 25
$55.3M
$5.8M
Q4 24
$64.3M
$-30.3M
Q3 24
$49.2M
$-654.0K
Q2 24
$39.9M
$3.3M
Gross Margin
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Operating Margin
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
38.0%
9.0%
Q3 25
39.3%
8.9%
Q2 25
39.6%
7.6%
Q1 25
39.4%
3.9%
Q4 24
43.3%
-17.7%
Q3 24
36.1%
-5.1%
Q2 24
27.5%
1.0%
Net Margin
FRME
FRME
RGEN
RGEN
Q1 26
17.9%
Q4 25
33.1%
6.7%
Q3 25
34.2%
7.9%
Q2 25
34.6%
8.2%
Q1 25
34.5%
3.4%
Q4 24
36.3%
-17.4%
Q3 24
31.5%
-0.4%
Q2 24
25.0%
2.2%
EPS (diluted)
FRME
FRME
RGEN
RGEN
Q1 26
$0.45
Q4 25
$0.98
$0.24
Q3 25
$0.98
$0.26
Q2 25
$0.98
$0.26
Q1 25
$0.94
$0.10
Q4 24
$1.09
$-0.55
Q3 24
$0.84
$-0.01
Q2 24
$0.68
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FRME
FRME
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$2.7B
$2.1B
Total Assets
$21.1B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
$767.6M
Q3 25
$748.7M
Q2 25
$708.9M
Q1 25
$697.2M
Q4 24
$757.4M
Q3 24
$784.0M
Q2 24
$809.1M
Total Debt
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
FRME
FRME
RGEN
RGEN
Q1 26
$2.7B
Q4 25
$2.5B
$2.1B
Q3 25
$2.4B
$2.1B
Q2 25
$2.3B
$2.1B
Q1 25
$2.3B
$2.0B
Q4 24
$2.3B
$2.0B
Q3 24
$2.3B
$2.0B
Q2 24
$2.2B
$2.0B
Total Assets
FRME
FRME
RGEN
RGEN
Q1 26
$21.1B
Q4 25
$19.0B
$2.9B
Q3 25
$18.8B
$2.9B
Q2 25
$18.6B
$2.9B
Q1 25
$18.4B
$2.9B
Q4 24
$18.3B
$2.8B
Q3 24
$18.3B
$2.8B
Q2 24
$18.3B
$2.9B
Debt / Equity
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FRME
FRME
RGEN
RGEN
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
$283.6M
$25.7M
Q3 25
$87.6M
$48.1M
Q2 25
$53.7M
$28.6M
Q1 25
$61.7M
$15.0M
Q4 24
$266.2M
$39.2M
Q3 24
$76.8M
$49.3M
Q2 24
$63.0M
$42.2M
Free Cash Flow
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
$17.6M
Q3 25
$43.4M
Q2 25
$21.5M
Q1 25
$11.4M
Q4 24
$33.6M
Q3 24
$42.3M
Q2 24
$37.4M
FCF Margin
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
8.9%
Q3 25
23.0%
Q2 25
11.8%
Q1 25
6.8%
Q4 24
19.3%
Q3 24
27.3%
Q2 24
24.3%
Capex Intensity
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
4.1%
Q3 25
2.5%
Q2 25
3.9%
Q1 25
2.1%
Q4 24
3.2%
Q3 24
4.5%
Q2 24
3.1%
Cash Conversion
FRME
FRME
RGEN
RGEN
Q1 26
Q4 25
4.97×
1.93×
Q3 25
1.54×
3.23×
Q2 25
0.94×
1.92×
Q1 25
1.11×
2.57×
Q4 24
4.14×
Q3 24
1.56×
Q2 24
1.58×
12.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FRME
FRME

Net Interest Income$151.3M96%
Noninterest Income$5.8M4%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons